SCHEMBL25340359

SCHEMBL25340359

CC(=O)N[C@@H](CSSC[C@H](NC(C)=O)C(=O)O)C(=O)O.[NaH].[NaH]

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.57
KDM4E B2RXH2 2/20 0.57
THRB P10828 1/20 0.57
ALOX15 P16050 1/20 0.57
NFKB1 P19838 1/20 0.57
PTGS2 P35354 1/20 0.57
THPO P40225 1/20 0.57
RECQL P46063 1/20 0.57
BLM P54132 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
ALDH1A1 P00352 3/20 0.55
ITGB1 P05556 3/20 0.46
ITGA4 P13612 3/20 0.46
TGFBR1 P36897 1/20 0.42
PRNP P04156 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
RAB9A P51151 1/20 0.39
GNPAT O15228 1/20 0.39
PAM P19021 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24067699 0.98 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL2140974 0.98 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL308082 0.98 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL25329304 0.98 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL308083 0.98 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL31253447 0.96 MAPT (0.57) MAPTKDM4ETHRBALOX15NFKB1
Water SCHEMBL8124987 0.96 MAPT (0.57) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL24378412 0.92 MAPT (0.53) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL26864072 0.92 MAPT (0.53) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL12442995 0.89 MAPT (0.55) MAPTKDM4ETHRBALOX15NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143161-B1 PROCESS OF MAKING N,N-DIACETYL-L-CYSTINE DISODIUM SALT FROM CYSTINE AND ACETYL CHLORIDE IN METHANOL IN THE PRESENCE OF SODIUM HYDROXIDE UNILEVER IP HOLDINGS B V (NL) 2023-11-01 EP disclosed
US-20230250055-A1 PROCESS OF MAKING N,N-DIACETYL-L-CYSTINE DISODIUM SALT FROM CYSTINE AND ACETYL CHLORIDE IN METHANOL IN THE PRESENCE OF SODIUM HYDROXIDE CONOPCO, INC., D/B/A UNILEVER (US) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250055-A1 PROCESS OF MAKING N,N-DIACETYL-L-CYSTINE DISODIUM SALT FROM CYSTINE AND ACETYL CHLORIDE IN METHANOL IN THE PRESENCE OF SODIUM HYDROXIDE CTH, CBS, SLC6A12 MAPT 2235/4885KDM4E 2020/4885THRB 3891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.